ArticleAnnals of surgical oncology2025
Integration of a Genetic Counselor into a Breast Health Center Improves Identification of Patients Needing Genetic Testing.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdentifying hereditary cancer predispositions is vital to providing personalized patient care for patients with breast cancer and their families. Determining who may benefit from genetic counseling and testing is complex. We conducted a retrospective analysis of patients presenting to our breast center to evaluate whether the integration of an on-site genetic counselor improved referral rates and completion of genetic testing for patients at increased genetic risk. PATIENTS AND
methodsA retrospective review was conducted on patients with newly diagnosed breast center, including assessment of personal and family cancer history. The National Comprehensive Cancer Network (NCCN) Hereditary Breast and Ovarian Cancer guidelines (version 2.2021) were applied to determine which patients met criteria for genetic testing. Chart reviews were also performed to identify whether patients were referred for genetic counseling, and, if so, whether they attended the session.
resultsMore than 1400 patient charts were reviewed from 2021 to 2022. In 2021, 70 patients (23.8%) that met NCCN criteria for genetic testing were either missed or not referred; this decreased to 35 (13.6%) missed referrals following the introduction of an on-site genetic counselor (p = 0.002). No significant difference was seen in the number of patients who attended a genetic counseling session (p = 0.832)
conclusionsThe integration of an on-site genetic counselor led to a significant reduction in the proportion of patients who were missed for genetic counseling referrals. This suggests that co-locating genetic counselors within the breast care team improves the identification of at-risk patients and enhances access to genetic counseling, thereby reducing barriers to comprehensive care for patients with newly diagnosed breast cancer.
Indexed as
Identifiers
40053269What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.